ABOUT SLA PHARMA
Pioneering gastrointestinal health solutions since 1997
Our Mission
At SLA Pharma, our mission is to improve patient lives by advancing innovative therapies across the spectrum of gastroenterological conditions. We focus on identifying known chemical entities to repurpose for new pharmacological indications bringing targeted, effective solutions to under-treated conditions in digestive health, gastrointestinal oncology, proctology, and rare GI disorders.
Quality Commitment
Maintaining the highest standards in research, development, and manufacturing
Research Excellence
Leading innovation in gastrointestinal health through rigorous research
Patient Focus
Putting patients first in everything we do
A Family Business with Decades of Experience and Expertise in Gastrointestinal Research, Development and Commercialisation
Founded by David Slagel, who previously founded Tillotts Pharma, known for Asacol
Now led by Justin Slagel, continuing the family's commitment to innovation
SLA Pharma has become a leader in clinical trial development for gastrointestinal disorders
We prioritise patient well-being and strive to improve their lives through access to innovative solutions
Our Values
The principles that guide our work and shape our culture
Integrity
Maintaining the highest ethical standards in all our operations and research
Innovation
Continuously pushing boundaries to develop better treatments
Patient Care
Putting patients at the heart of everything we do